Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Hodgekiss, J. Slough, T. Capstick, D. Peckham, I. Clifton (Leeds, United Kingdom). Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis. Eur Respir J 2013; 42: Suppl. 57, 745

Member's Comments

No comment yet.

Related content which might interest you: Effects of hypertonic saline on sputum clearance in patients with bronchiectasis Source: International Congress 2016 – Best abstracts on innovative outcomes and novel interventions in respiratory physiotherapy Year: 2016 Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 A cross-over study to compare the Lung Flute™ to hypertonic saline inhalation about the performance of inducing sputum for the diagnosis of pulmonary tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Clinical surveys with nebulised hypertonic saline (HS) in CF children Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 LATE-BREAKING ABSTRACT: Safety and efficacy of inhaled mannitol over 12 months in high-risk patients with non-CF bronchiectasis Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 304s Year: 2005 Inhalation therapy with hypertonic saline (3%) – A treatment option for airway disease in children? Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions Year: 2009 Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Safety and efficacy of emphysematous lung sealant (ELS) therapy for advanced emphysema out to 2 years Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining Year: 2011 The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Success rate of sputum induction in the Leicester paediatric severe asthma clinic using nebulised hypertonic saline: A 2-year review Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010 Preliminary results of study of bronchoscopic hot saline ablation (BHSA) treatment, in emphysematous lung disease Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Pulmonary targeted antibiotics in bronchiectasis; inhalers vs. nebulisers. A qualitative and quantitative assessment of patients’ attitudes Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Safety and efficacy of ectoine inhalation solution in patients with inflammation and airway obstruction: The EFECT study Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014